methimazole and Raynaud-Disease

Cryofibrinogenemia is a cryopathy in which hypersensitivity to cold is a prominent feature. Cryofibrinogenemia developed in an 18-year-old Japanese female patient during methimazole therapy for Graves' disease. She developed cryopathy (livedo reticularis, Raynaud's phenomenon and acral ulcer) and polyarthralgia during methimazole therapy, and we detected cryofibrinogen in her plasma. Her symptoms resolved after administration of prostaglandins and anticoagulants. Several reports indicate that methimazole therapy induces autoantibody-related disease. In the present case, we cannot exclude the possibility that methimazole therapy contributed to the cryofibrinogenemia.

Topics: Adolescent; Anticoagulants; Antithyroid Agents; Arthralgia; Cryoglobulins; Female; Fibrinogens, Abnormal; Foot Ulcer; Graves Disease; Humans; Methimazole; Prostaglandins, Synthetic; Raynaud Disease; Skin Diseases, Vascular